A lot of research showed that GLP-1 mimetic drugs or GLP-1 availability modulating drugs as DDP4 inhibitors have neuroprotective, neurotrophic, and anti-inflammatory effects, which can play important role in retardation of cognitive impairment progression38–41,43,44,86,88–90. Here, GCG is linked to Cognitive impairment.